Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) shares rose 12.1% during mid-day trading on Monday . The stock traded as high as GBX 1.60 and last traded at GBX 1.57. Approximately 117,544 shares were traded during mid-day trading, a decline of 74% from the average daily volume of 454,720 shares. The stock had previously closed at GBX 1.40.
Cizzle Biotechnology Stock Performance
The stock has a market capitalization of £5.15 million, a price-to-earnings ratio of -4.06 and a beta of 0.38. The business has a fifty day simple moving average of GBX 1.50 and a 200 day simple moving average of GBX 1.53.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Featured Stories
- Five stocks we like better than Cizzle Biotechnology
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- This makes me furious
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
